F
Fabien Zoulim
Researcher at French Institute of Health and Medical Research
Publications - 716
Citations - 40988
Fabien Zoulim is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Hepatitis B virus & Hepatitis B. The author has an hindex of 96, co-authored 641 publications receiving 35807 citations. Previous affiliations of Fabien Zoulim include Hotel Dieu Hospital & University of Orléans.
Papers
More filters
Posted ContentDOI
Landscape of oncoviral genotype and co-infection via Human papilloma and Hepatitis B viral tumor in-situ profiling
Adrian Bubie,Fabien Zoulim,Barbara Testoni,Brett A. Miles,Marshall R. Posner,Augusto Villanueva,Bojan Losic +6 more
TL;DR: A new scalable, high throughput tool (ViralMine) is developed and deployed for sensitive and precise oncoviral genotype deconvolution using tumor RNA sequencing data from 537 virally infected liver, cervical, and head and neck tumors, finding that HBV and HPV genotype serve as significant predictors of patient survival, tumor immune responsiveness, and APOBEC activity modulation.
Journal ArticleDOI
Is treatment with Bulevirtide 10 mg useful in poor responder patients to 2 mg? Results from the French multicenter early access program
Victor de Ledinghen,Anne Minello Franza,Nathalie Ganne-Carrié,Laurent Alric,Sophie Metivier,Martin Siguier,B Prouvost-Keller,Bruno Roche,Frédéric Heluwaert,Louis d’Alteroche,Leon Muti,Juliette Foucher,Fabien Zoulim,Marie-Noëlle Hilleret +13 more
Journal ArticleDOI
Emerging anti-HDV drugs and HBV cure strategies with anti-HDV activity.
Armando Andres Roca Suarez,Enkhtuul Batbold,Birke Bartosch,Naranjargal Dashdorj,Barbara Testoni,Fabien Zoulim +5 more
TL;DR: In this paper , the authors summarized the ongoing efforts to evaluate promising HDV-specific drugs, such as lonafarnib (LNF), pegylated interferon lambda (PEG-IFN-λ) and their use as a combination therapy.
Journal ArticleDOI
Prevalence of diagnosed advanced liver fibrosis in high-risk population with metabolic-dysfunction associated fatty liver disease screened in diabetology using transient elastography
Adrien Aubin,Marianne Maynard,Berenice Segrestin,Yasmina Chouik,Laurent Milot,Valérie Hervieu,Fabien Zoulim,Emmanuel Disse,Massimo Levrero,Cyrielle Caussy +9 more
Journal ArticleDOI
Hepatitis B Virus Genome Diversity in Adolescents: Tenofovir Disoproxil Fumarate Treatment Effect and HBeAg Seroconversion
Christophe Combet,Neeru Bhardwaj,Charlotte Hedskog,Ondrej Podlaha,Anuj Gaggar,Karen F. Murray,Hongmei Mo,Evguenia S. Svarovskaia,Fabien Zoulim,Fabien Zoulim +9 more
TL;DR: More systematic analysis of hepatitis B virus (HBV) genome diversity, linked with tenofovir disoproxil fumarate (TDF) treatment and HBeAg seroconversion, are needed.